The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.
Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.
Johnson & Johnson (NYSE:JNJ) is included among the 12 Reliable Dividend Stocks for Maximum Income. Johnson & Johnson ...
Johnson & Johnson on Tuesday said it plans to separate its orthopedics business into a standalone company named DePuy Synthes ...
Guidance was raised again, with operational sales growth midpoint moving to 5.1% (previous: 4.8%) and reported sales growth midpoint at 5.7% (previous: 5.4%), reflecting increased confidence in both ...
Johnson & Johnson MedTech has been involved in some of the biggest medtech M&A deals in recent years and that trend is likely ...
8hon MSN
Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff
Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate its orthopedics business.
Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback